Mangrove Partners Travere Therapeutics, Inc. Transaction History

Mangrove Partners

  • $769 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$7.64 - $17.25 $7.22 Million - $16.3 Million
945,417 New
945,417 $8.45 Million
Q2 2022

Aug 15, 2022
SELL
$20.94 - $30.01 $13.7 Million - $19.6 Million
-652,372 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$12.98 - $25.03 $4.64 Million - $8.94 Million
357,335 Added 121.12%
652,372 $15.8 Million
Q2 2021

Aug 16, 2021
BUY
$14.11 - $26.4 $4.16 Million - $7.79 Million
295,037 New
295,037 $4.31 Million

Others Institutions Holding TVTX

# of Institutions
199
Shares Held
85.2M
Call Options Held
776K
Put Options Held
912K
View Full List

About Travere Therapeutics, Inc.

TVTX Quotes by TradingView
  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.35B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Mangrove Partners Portfolio

Follow Mangrove Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mangrove Partners, based on Form 13F filings with the SEC.

News

Stay updated on Mangrove Partners with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email